We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial.
- Authors
Verweij, Jaap; Casali, Paolo G; Zalcberg, John; LeCesne, Axel; Reichardt, Peter; Blay, Jean-Yves; Issels, Rolf; van Oosterom, Allan; Hogendoorn, Pancras C W; Van Glabbeke, Martine; Bertulli, Rossella; Judson, Ian
- Abstract
Imatinib is approved worldwide for use in gastrointestinal stromal tumours (GIST). We aimed to assess dose dependency of response and progression-free survival with imatinib for metastatic GIST.
- Publication
Lancet (London, England), 2004, Vol 364, Issue 9440, p1127
- ISSN
1474-547X
- Publication type
Journal Article
- DOI
10.1016/S0140-6736(04)17098-0